Form 4: Tenet Healthcare Officer Sells All Shares

Tenet Healthcare's Principal Accounting Officer, R. Scott Ramsey, sold all 13,322 beneficially owned shares of common stock on November 6, 2025, under a pre-arranged trading plan.

Summary

• R. Scott Ramsey, Principal Accounting Officer of Tenet Healthcare Corp (THC), reported the sale of common stock.
• The transactions occurred on November 6, 2025, under a Rule 10b5-1(c) pre-arranged trading plan.
• A total of 13,322 shares were sold across three separate transactions.
• The first sale involved 8,056 shares at a weighted average price of $204.75 per share, with individual prices ranging from $204.21 to $205.13.
• The second sale involved 5,066 shares at a weighted average price of $205.62 per share, with individual prices ranging from $205.21 to $206.14.
• The third sale involved 200 shares at a price of $206.51 per share.
• Following these transactions, R. Scott Ramsey's direct beneficial ownership of Tenet Healthcare common stock is 0 shares.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction under a pre-arranged 10b5-1 plan, which is generally considered neutral in terms of immediate company sentiment.

Positives

• The sales were conducted under a Rule 10b5-1(c) plan, indicating they were pre-scheduled and not based on new, non-public information, which can mitigate negative perceptions of insider selling.

Negatives

• A Principal Accounting Officer selling all beneficially owned shares could be interpreted by some investors as a lack of confidence, despite the pre-arranged trading plan.

Risks

• NA

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders may note the complete divestment of shares by a key executive, though the pre-arranged nature of the sale under a 10b5-1 plan typically lessens concerns about its implications for company performance.

Key Dates

Recommendation

The filing reports a routine insider stock sale by a Principal Accounting Officer under a pre-arranged 10b5-1 trading plan. This type of transaction is generally not considered a significant indicator for the company's fundamental performance or future stock price direction, thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Tenet Healthcare, THC, Insider Trading, Form 4, Stock Sale, R. Scott Ramsey, Principal Accounting Officer, 10b5-1 Plan